TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 2.30nMAssay Description:Inhibition of mTOR (unknown origin) after 40 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 2.40nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2/PS as substrate compound preincubated for 15 mins by luciferase-based luminescence assayMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 2.5nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2/PS as substrate compound preincubated for 15 mins by luciferase-based luminescence assayMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 2.80nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2/PS as substrate compound preincubated for 15 mins by luciferase-based luminescence assayMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 2.90nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2/PS as substrate compound preincubated for 15 mins by luciferase-based luminescence assayMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 3.40nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2/PS as substrate compound preincubated for 15 mins by luciferase-based luminescence assayMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 3.60nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2/PS as substrate compound preincubated for 15 mins by luciferase-based luminescence assayMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 6nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2/PS as substrate compound preincubated for 15 mins by luciferase-based luminescence assayMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 6nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2/PS as substrate compound preincubated for 15 mins by luciferase-based luminescence assayMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 6.5nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2/PS as substrate compound preincubated for 15 mins by luciferase-based luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 7.90nMAssay Description:Inhibition of mTOR (unknown origin) after 40 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 8.30nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2/PS as substrate compound preincubated for 15 mins by luciferase-based luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 8.5nMAssay Description:Inhibition of mTOR (unknown origin) after 40 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 8.60nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2/PS as substrate compound preincubated for 15 mins by luciferase-based luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 8.60nMAssay Description:Inhibition of mTOR (unknown origin) after 40 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 9.90nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2/PS as substrate compound preincubated for 15 mins by luciferase-based luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 11nMAssay Description:Inhibition of mTOR (unknown origin) after 40 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 12nMAssay Description:Inhibition of mTOR (unknown origin) after 40 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 12nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2/PS as substrate compound preincubated for 15 mins by luciferase-based luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 13nMAssay Description:Inhibition of mTOR (unknown origin) after 40 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2/PS as substrate compound preincubated for 15 mins by luciferase-based luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:Inhibition of mTOR (unknown origin) after 40 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:Inhibition of mTOR (unknown origin) after 40 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2/PS as substrate compound preincubated for 15 mins by luciferase-based luminescence assayMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 15nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2/PS as substrate compound preincubated for 15 mins by luciferase-based luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 18nMAssay Description:Inhibition of mTOR (unknown origin) after 40 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 19nMAssay Description:Inhibition of mTOR (unknown origin) after 40 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 23nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2/PS as substrate compound preincubated for 15 mins by luciferase-based luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 25nMAssay Description:Inhibition of mTOR (unknown origin) after 40 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 29nMAssay Description:Inhibition of mTOR (unknown origin) after 40 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 30nMAssay Description:Inhibition of mTOR (unknown origin) after 40 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 31nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2/PS as substrate compound preincubated for 15 mins by luciferase-based luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 34nMAssay Description:Inhibition of mTOR (unknown origin) after 40 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 35nMAssay Description:Inhibition of mTOR (unknown origin) after 40 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 35nMAssay Description:Inhibition of mTOR (unknown origin) after 40 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 35nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2/PS as substrate compound preincubated for 15 mins by luciferase-based luminescence assayMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 36nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2/PS as substrate compound preincubated for 15 mins by luciferase-based luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 37nMAssay Description:Inhibition of mTOR (unknown origin) after 40 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 37nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2/PS as substrate compound preincubated for 15 mins by luciferase-based luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 39nMAssay Description:Inhibition of mTOR (unknown origin) after 40 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 40nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2/PS as substrate compound preincubated for 15 mins by luciferase-based luminescence assayMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 43nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2/PS as substrate compound preincubated for 15 mins by luciferase-based luminescence assayMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 61nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2/PS as substrate compound preincubated for 15 mins by luciferase-based luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 63nMAssay Description:Inhibition of mTOR (unknown origin) after 40 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 66nMAssay Description:Inhibition of mTOR (unknown origin) after 40 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 69nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2/PS as substrate compound preincubated for 15 mins by luciferase-based luminescence assayMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 73nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2/PS as substrate compound preincubated for 15 mins by luciferase-based luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 78nMAssay Description:Inhibition of mTOR (unknown origin) after 40 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 82nMAssay Description:Inhibition of mTOR (unknown origin) after 40 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Pkucare Pharmaceutical R & D Center
Curated by ChEMBL
Affinity DataIC50: 117nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2/PS as substrate compound preincubated for 15 mins by luciferase-based luminescence assayMore data for this Ligand-Target Pair